HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jury Still Out On Feminine-Hygiene Talc Safety, Except In The Courts

This article was originally published in The Rose Sheet

Executive Summary

Health and scientific authorities have taken various positions on the possible link between perineal talcum-powder use and ovarian cancer, including that the substance is safe as used, is "possibly carcinogenic" and that data is insufficient to allow for a conclusive assessment. Juries in J&J talc trials have been more convinced of the talc-cancer correlation and the firm's negligence in not warning consumers about risks.

Advertisement

Related Content

J&J Talc Suit Dismissals: Plaintiffs Lack Causation Thread For Proof Quilt
J&J Slapped With Another Talc Cancer Verdict As More Claimants Line Up

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS019897

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel